TYMS
Gene Information
- Official Symbol: TYMS
- Official Name: thymidylate synthetase
- Aliases and Previous Symbols: N/A
- Entrez ID: 7298
- UniProt: P04818
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: Thymidylate synthase catalyzes the methylation of deoxyuridylate to deoxythymidylate using, 10-methylenetetrahydrofolate (methylene-THF) as a cofactor. This function maintains the dTMP (thymidine-5-prime monophosphate) pool critical for DNA replication and repair. The enzyme has been of interest as a target for cancer chemotherapeutic agents. It is considered to be the primary site of action for 5-fluorouracil, 5-fluoro-2-prime-deoxyuridine, and some folate analogs. Expression of this gene and that of a naturally occurring antisense transcript, mitochondrial enolase superfamily member 1 (GeneID:55556), vary inversely when cell-growth progresses from late-log to plateau phase. Polymorphisms in this gene may be associated with etiology of neoplasia, including breast cancer, and response to chemotherapy. [provided by RefSeq, Aug 2017].
- UniProt Summary: Contributes to the de novo mitochondrial thymidylate biosynthesis pathway. {ECO:0000269|PubMed:21876188}.
Pfam Domains GO Terms
Pfam Domains
| Thymidylat synt |
GO Terms
| immortalization of host cell by virus |
| immortalization of host cell |
| thymidylate synthase activity |
| uracil metabolic process |
| transformation of host cell by virus |
| dTMP metabolic process |
| dTMP biosynthetic process |
| dTTP biosynthetic process |
| intestinal epithelial cell maturation |
| pyrimidine deoxyribonucleoside triphosphate biosynthetic process |
| dTTP metabolic process |
| deoxyribonucleoside triphosphate biosynthetic process |
| dUMP metabolic process |
| pyrimidine deoxyribonucleoside monophosphate biosynthetic process |
| pyrimidine deoxyribonucleoside monophosphate metabolic process |
| pyrimidine deoxyribonucleoside triphosphate metabolic process |
| columnar/cuboidal epithelial cell maturation |
| pyrimidine deoxyribonucleotide biosynthetic process |
| response to folic acid |
| deoxyribonucleoside monophosphate biosynthetic process |
| intestinal epithelial cell development |
| tetrahydrofolate interconversion |
| sequence-specific mRNA binding |
| deoxyribose phosphate biosynthetic process |
| folic acid binding |
| 2-deoxyribonucleotide biosynthetic process |
| deoxyribonucleoside monophosphate metabolic process |
| deoxyribonucleotide biosynthetic process |
| translation repressor activity, mRNA regulatory element binding |
| pyrimidine nucleoside monophosphate biosynthetic process |
| epithelial cell maturation |
| pyrimidine nucleoside monophosphate metabolic process |
| deoxyribonucleoside triphosphate metabolic process |
| cofactor binding |
| tetrahydrofolate metabolic process |
| pyrimidine nucleoside triphosphate biosynthetic process |
| response to vitamin A |
| intestinal epithelial cell differentiation |
| pyrimidine deoxyribonucleotide metabolic process |
| pyrimidine nucleobase metabolic process |
| pyrimidine nucleoside triphosphate metabolic process |
| one-carbon metabolic process |
| regulation of transcription involved in G1/S transition of mitotic cell cycle |
| folic acid-containing compound metabolic process |
| nucleobase-containing small molecule interconversion |
| liver regeneration |
| 2-deoxyribonucleotide metabolic process |
| modulation by virus of host morphology or physiology |
| deoxyribose phosphate metabolic process |
| pteridine-containing compound metabolic process |
| deoxyribonucleotide metabolic process |
| modification by symbiont of host morphology or physiology |
| nucleobase metabolic process |
| nucleoside monophosphate biosynthetic process |
| response to progesterone |
| pyrimidine nucleotide biosynthetic process |
| columnar/cuboidal epithelial cell development |
| pyrimidine-containing compound biosynthetic process |
| nucleotide binding |
| pyrimidine nucleotide metabolic process |
| nucleoside triphosphate biosynthetic process |
| nucleoside monophosphate metabolic process |
| animal organ regeneration |
| response to vitamin |
| nucleoside triphosphate metabolic process |
| columnar/cuboidal epithelial cell differentiation |
| pyrimidine-containing compound metabolic process |
| DNA biosynthetic process |
| modification of morphology or physiology of other organism involved in symbiotic interaction |
| G1/S transition of mitotic cell cycle |
| cell cycle G1/S phase transition |
| liver development |
| response to ethanol |
| hepaticobiliary system development |
| negative regulation of translation |
| digestive tract development |
| anatomical structure maturation |
| response to organophosphorus |
| circadian rhythm |
| digestive system development |
| response to glucocorticoid |
| negative regulation of cellular amide metabolic process |
| modification of morphology or physiology of other organism |
| interaction with host |
| regeneration |
| cell maturation |
| response to corticosteroid |
| cartilage development |
| epithelial cell development |
| response to ketone |
| cellular modified amino acid metabolic process |
| response to nutrient |
| connective tissue development |
| response to alcohol |
| developmental maturation |
| nucleotide biosynthetic process |
| nucleoside phosphate biosynthetic process |
| coenzyme metabolic process |
| mitotic cell cycle phase transition |
| rhythmic process |
| aging |
| cell cycle phase transition |
| response to antibiotic |
| methylation |
| response to steroid hormone |
| response to acid chemical |
| regulation of translation |
| mitochondrial matrix |
| developmental growth |
| growth |
| mitochondrial inner membrane |
| regulation of cellular amide metabolic process |
| gland development |
| cofactor metabolic process |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| skeletal system development |
| response to nutrient levels |
| drug metabolic process |
| response to toxic substance |
| posttranscriptional regulation of gene expression |
| response to extracellular stimulus |
| organophosphate biosynthetic process |
| nucleobase-containing small molecule metabolic process |
| mitotic cell cycle process |
| carbohydrate derivative biosynthetic process |
| epithelial cell differentiation |
| mitotic cell cycle |
| viral process |
| DNA metabolic process |
| symbiotic process |
| cellular amide metabolic process |
| interspecies interaction between organisms |
| tube development |
| response to lipid |
| nucleolus |
| protein homodimerization activity |
| organophosphate metabolic process |
| carboxylic acid metabolic process |
| response to hormone |
| response to organic cyclic compound |
| cell cycle process |
| response to organonitrogen compound |
| oxoacid metabolic process |
| response to drug |
| organic acid metabolic process |
| carbohydrate derivative metabolic process |
| negative regulation of cellular protein metabolic process |
| response to nitrogen compound |
| nucleobase-containing compound biosynthetic process |
| response to cytokine |
| negative regulation of protein metabolic process |
| epithelium development |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| mitochondrion |
| organic cyclic compound biosynthetic process |
| cell cycle |
| negative regulation of cellular macromolecule biosynthetic process |
| organonitrogen compound biosynthetic process |
| negative regulation of macromolecule biosynthetic process |
| response to endogenous stimulus |
| negative regulation of cellular biosynthetic process |
| negative regulation of biosynthetic process |
| response to oxygen-containing compound |
| cellular nitrogen compound biosynthetic process |
| cell development |
| cellular macromolecule biosynthetic process |
| negative regulation of gene expression |
| small molecule metabolic process |
| tissue development |
| macromolecule biosynthetic process |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| POLR2J3 | 0.712 |
| PRIM1 | 0.571 |
| AATF | 0.551 |
| TCEB3CL | 0.548 |
| TCEB3C | 0.541 |
| TCEB3CL2 | 0.541 |
| PSMB2 | 0.538 |
| PSMB4 | 0.527 |
| DTL | 0.518 |
| AQR | 0.516 |
| ATP6V1B2 | 0.515 |
| MED14 | 0.513 |
| VPS28 | 0.512 |
| TICRR | 0.51 |
| CCNA2 | 0.502 |
| SLC4A1 | 0.501 |
| NPIPB5 | 0.497 |
| COPG1 | 0.496 |
| TBC1D3H | 0.495 |
| CBWD3 | 0.495 |
| GOLGA6L1 | 0.493 |
| CBWD6 | 0.491 |
| NUPL1 | 0.487 |
| EXOSC6 | 0.484 |
| GAR1 | 0.484 |
| TBC1D3C | 0.482 |
| RRP7A | 0.482 |
| COL2A1 | 0.481 |
| MED17 | 0.48 |
| TBC1D3I | 0.479 |
| TBC1D3E | 0.478 |
| C14orf93 | 0.478 |
| ATP6V1A | 0.478 |
| TBC1D3L | 0.477 |
| TBC1D3K | 0.477 |
| TBC1D3F | 0.477 |
| TBC1D3G | 0.476 |
| COPB1 | 0.476 |
| NSF | 0.475 |
| BYSL | 0.474 |
| TFIP11 | 0.472 |
| IK | 0.471 |
| CBWD5 | 0.466 |
| RPS2 | 0.466 |
| SF3A1 | 0.466 |
| POLR1A | 0.462 |
| CHAF1A | 0.462 |
| TBC1D3 | 0.461 |
| MT1E | 0.461 |
| PSMD3 | 0.459 |
| CHD4 | 0.458 |
| POLE | 0.458 |
| CACTIN | 0.457 |
| C1QTNF9B | 0.456 |
| DOCK6 | 0.455 |
| ATP6AP1 | 0.455 |
| AKT1S1 | 0.455 |
| DHX38 | 0.455 |
| UTP3 | 0.454 |
| DDX47 | 0.451 |
| NOL12 | 0.451 |
| ANKLE2 | 0.449 |
| TIMELESS | 0.449 |
| EXOSC9 | 0.447 |
| TWISTNB | 0.447 |
| ORC1 | 0.445 |
| WDR75 | 0.443 |
| PSMB1 | 0.442 |
| CDCA3 | 0.441 |
| POLD1 | 0.44 |
| PSMC6 | 0.438 |
| PSMC2 | 0.438 |
| MDN1 | 0.437 |
| PSMA6 | 0.437 |
| SNIP1 | 0.434 |
| CEP192 | 0.434 |
| SUPT5H | 0.433 |
| PSMD7 | 0.433 |
| UTP20 | 0.431 |
| SMTN | 0.431 |
| CHCHD3 | 0.431 |
| IGFN1 | 0.43 |
| ANKLE1 | 0.43 |
| DNTTIP2 | 0.43 |
| ORC6 | 0.43 |
| EXOSC3 | 0.43 |
| PAN3 | 0.428 |
| XAB2 | 0.428 |
| HIST2H3C | 0.428 |
| HIST2H3A | 0.428 |
| UPF1 | 0.428 |
| RPLP1 | 0.427 |
| PLXNB3 | 0.427 |
| RRP15 | 0.426 |
| CDH24 | 0.425 |
| ATP6AP2 | 0.425 |
| TRAPPC8 | 0.423 |
| RPL35 | 0.419 |
| NOL10 | 0.419 |
| ITGAX | 0.419 |
| GID4 | 0.418 |
| RPS12 | 0.417 |
| SMG1 | 0.416 |
| POLR2D | 0.416 |
| USP35 | 0.416 |
| POLR2J | 0.416 |
| OGFR | 0.416 |
| ATP6V1C1 | 0.415 |
| NUP153 | 0.415 |
| PHF2 | 0.415 |
| NUP160 | 0.415 |
| SLC6A17 | 0.411 |
| TAF1 | 0.41 |
| TP53TG3C | 0.41 |
| TP53TG3 | 0.41 |
| TP53TG3B | 0.41 |
| PLEKHA4 | 0.409 |
| POLR2F | 0.409 |
| NARFL | 0.408 |
| RFXANK | 0.407 |
| RPL6 | 0.406 |
| ZNF830 | 0.406 |
| LRR1 | 0.406 |
| VASN | 0.405 |
| SNRPA1 | 0.405 |
| ATP6V0C | 0.405 |
| PSMD2 | 0.405 |
| GBF1 | 0.404 |
| HIVEP3 | 0.404 |
| COX7A2L | 0.404 |
| HEATR1 | 0.403 |
| OSBP | 0.403 |
| COPA | 0.403 |
| GOLGA6L4 | 0.403 |
| RPA2 | 0.402 |
| DISP2 | 0.402 |
| FAM231C | 0.401 |
| KCTD17 | 0.401 |
| FAM231A | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 166/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 8/28 |
| blood | 14/28 |
| bone | 5/26 |
| breast | 15/33 |
| central nervous system | 6/56 |
| cervix | 1/4 |
| colorectal | 3/17 |
| esophagus | 2/13 |
| fibroblast | 0/1 |
| gastric | 5/16 |
| kidney | 3/21 |
| liver | 3/20 |
| lung | 21/75 |
| lymphocyte | 0/16 |
| ovary | 2/26 |
| pancreas | 6/24 |
| peripheral nervous system | 5/16 |
| plasma cell | 4/15 |
| prostate | 1/1 |
| skin | 5/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 4/22 |
| urinary tract | 4/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 59
- Expression level (log2 read counts): 8.07
Expression Distribution
TYMS Expression in NALM6 Cells: 8.07